• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Gland Pharma Ltd.
    21 Jan 2025
    2017.20
    0.12%
    Gland Pharma Gets 'Neutral' Upgrade From Nomura But Target Price Slashed Here's Why
    Gland Pharma Gets 'Neutral' Upgrade From Nomura But Target Price Slashed Here's Why
    NDTV Profit
    Gland Pharma's third quarter results showed a dip in US exports.
    Copy LinkShare onShare on Share on Share on
    Gland Pharma Ltd. is trading above all available SMAs
    V
    Vasundhara Rasayans Ltd.
    20 Jan 2025
    186.65
    -2.76%
    Fitch upgrades Vedanta Resources' long-term ratings with stable outlook
    Business Standard
    Fitch has upgraded Vedanta Resources Ltd's (VRL) long-term foreign-currency issuer default rating following a "significant reduction" in the company's refinancing risks. The rating agency upgraded VRL's senior unsecured rating to 'B+' from 'B-' and also changed the outlook to stable, according to a statement. Besides, it has upgraded "the ratings on the USD 300 million June 2028 bonds and USD 500 million December 2031 bonds, issued by VRL's subsidiary Vedanta Resources Finance II Plc (VRF2), and unconditionally and irrevocably guaranteed by VRL, to 'B+' from 'B-' with Recovery Rating of 'RR4'," the statement said. The upgrade follows a significant reduction in VRL's refinancing risks, after it raised USD 1.1 billion in new bonds and received bank commitments for loans worth USD 350 million at the holding company, formed by VRL and other offshore investment holding companies owned by VRL, in January 2025, the statement said. Once the proceeds are used to refinance existing debt, the
    Copy LinkShare onShare on Share on Share on
    Vasundhara Rasayans Ltd. has lost -27.50% in the last 6 Months
    logo
    Strides Pharma Science Ltd.
    20 Jan 2025
    854.10
    -0.25%
    Strides Pharma's Arm Gets US FDA Approval For Pain Relief Tablets
    Strides Pharma's Arm Gets US FDA Approval For Pain Relief Tablets
    NDTV Profit
    Strides Pharma has received the approval for Acetaminophen and Ibuprofen over-the-counter tablets of 125 mg and 250 mg from the US FDA.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 268 to 287 in Jun 2025 qtr.
    logo
    Dr. Reddy's Laboratories Ltd.
    20 Jan 2025
    1308.40
    0.54%
    Dr Reddy's Labs Q3 Preview: Revlimid to dent US sales, profits may rise 12%
    Business Standard
    Indian pharmaceutical (IT) major, Dr Reddy's Laboratories, is scheduled to deliver its October-December quarterly earnings for the financial year 2024-25 (Q3FY25) on Thursday, January 23, 2025
    Copy LinkShare onShare on Share on Share on
    Deven Choksey released a Sell report for Dr. Reddy's Laboratories Ltd. with a price target of 1120.0 on 11 Sep, 2025.
    logo
    Sigachi Industries Ltd.
    20 Jan 2025
    42.21
    -1.42%
    Sigachi Industries shares zoom 7% after net profit soars 27% in Q3 results
    Business Standard
    Sigachi Industries share price jumped 7.08 per cent at Rs 55.66 a piece on the BSE in Monday's intraday trade
    Copy LinkShare onShare on Share on Share on
    Sigachi Industries Ltd. has lost -22.86% in the last 3 Months
    Sigachi Industries share price jumps over 7% after Q3 results 2025
    livemint | 20 Jan 2025
    logo
    Dr. Reddy's Laboratories Ltd.
    20 Jan 2025
    1308.40
    0.54%
    Dr Reddy Share Price Live blog for 20 Jan 2025
    Dr Reddy Share Price Live blog for 20 Jan 2025
    livemint
    Dr Reddy Share Price Today Live Updates : Dr Reddy stock price went up today, 20 Jan 2025, by 0.5 %. The stock closed at 1303.3 per share. The stock is currently trading at 1309.85 per share. Investors should monitor Dr Reddy stock price closely in the coming days and weeks to see how it reacts to the news.
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
    logo
    Sun Pharmaceutical Industries Ltd.
    19 Jan 2025
    1631.20
    -0.78%
    Indian Pharma Q3 Preview: Analysts See Domestic Formulations, US Shortage Driving Growth
    Indian Pharma Q3 Preview: Analysts See Domestic Formulations, US Shortage Driving Growth
    NDTV Profit
    Sun Pharma to Dr. Reddy's, here is what analysts expect for Indian pharma firms in the third quarter of fiscal 2025.
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical Industries Ltd. is trading below its 50 day SMA of 1638.0
    F&O Query: Should you hold put option on Sun Pharma and HUDCO?
    Business Line | 18 Jan 2025
    logo
    Glenmark Pharmaceuticals Ltd.
    18 Jan 2025
    Board Meeting
    2016.80
    -0.05%
    Glenmark Pharma retrenches over 100 personnel from its consumer care division
    Business Line
    Cites business review for efficiency and competitiveness in evolving market
    Copy LinkShare onShare on Share on Share on
    Geojit BNP Paribas increased Accumulate price target of Glenmark Pharmaceuticals Ltd. to 2306.0 on 09 Sep, 2025.
    logo
    Gland Pharma Ltd.
    18 Jan 2025
    2017.20
    0.12%
    Gland Pharma's Hyderabad Facility Receives Establishment Inspection Report From USFDA
    Gland Pharma's Hyderabad Facility Receives Establishment Inspection Report From USFDA
    NDTV Profit
    In August 2024, the US FDA concluded the inspection with three observations.
    Copy LinkShare onShare on Share on Share on
    Gland Pharma Ltd. has gained 27.24% in the last 6 Months
    logo
    Dr. Reddy's Laboratories Ltd.
    17 Jan 2025
    1308.40
    0.54%
    Dr Reddy's and Dr Reddy's Foundationopen soil testing resource centre
    Business Line
    The 14,750-sqft facility houses advanced instruments and systems, providing analysis of over 18 parameters.
    Copy LinkShare onShare on Share on Share on
    Deven Choksey released a Sell report for Dr. Reddy's Laboratories Ltd. with a price target of 1120.0 on 11 Sep, 2025.
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • GK Energy
    • Saatvik Green Energy
    • Siddhi Cotspin
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd